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Abstract  Endoleaks  have  been  referred  to  as  the  ‘‘Achilles  heel’’  of  endovascular  aortic
aneurysm repair  (EVAR)  and  are  the  most  common  complication  of  this  procedure.  An  endoleak
can maintain  a  high  systemic  blood  pressure  within  the  aneurysm  sac,  potentially  leading  to
rupture. Follow-up  is  therefore  mandatory  to  detect  and  classify  possible  endoleaks.  Com-
puted tomography  (CT)  remains  the  gold  standard  for  follow-up,  but  provides  no  hemodynamic
information  on  endoleaks  and  has  the  disadvantages  of  exposing  patients  to  iodine  contrast
and X-ray  radiation.  Exposure  to  radiation  could  be  reduced  in  various  ways,  by  simplifying
the triphasic  protocol  using  dual-energy  CT  imaging,  limiting  the  amount  of  radiation  per  slice
using iterative  reconstruction,  and  reducing  the  follow-up  schedule  that  could  be  altered  to
include non-ionizing  radiation  imaging  techniques.  Contrast-enhanced  ultrasound  (CEUS)  is  an
interesting  alternative  to  CT,  as  is  magnetic  resonance  (MR)  imaging  that  can  be  used  as  an
alternative  or  for  complementary  imaging.  Long-term  follow-up  schedules  are  currently  based
on repeated  CT.  However,  more  recently  alternative  follow-up  protocols  have  been  proposed
for patients  with  no  endoleaks  nor  increase  in  aneurysmal  sac  size.  These  new  protocols  consist
of CT  imaging  at  1  month  and  1  year  after  treatment,  subsequently  followed  by  CEUS.  Never-
theless, the  mechanical  structure  of  the  stent-graft  must  still  be  veriﬁed  by  CT.  The  use  of
patient-speciﬁc  risk-adjusted  follow-up  protocols,  based  on  preoperative  imaging  and  the  ﬁrst
postoperative  results,  is  gradually  becoming  more  and  more  widespread.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.∗ Corresponding author at: Pôle de radiologie, CHU de Clermont-Ferran
E-mail address: lcassagnes@chu-clermontferrand.fr (L. Cassagnes).
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hy is it essential to diagnose and classify
ndoleaks?
ndoleaks  occur  when  the  aneurysmal  sac  continues  to  be
ressurized  following  the  placement  of  an  aortic  stent-graft.
hey  are  often  referred  to  as  the  ‘‘Achilles  heel’’  of  the
ndovascular  approach  to  both  abdominal  endovascular  aor-
ic  repair  (EVAR)  and  thoracic  endovascular  aortic  repair
TEVAR)  procedures.
In 1998,  White  et  al.  [1]  classiﬁed  endoleaks  into  ﬁve
ypes:
type  1:  leak  between  the  stent  and  the  aortic  or  iliac  wall.
There  are  four  type-1  subtypes:
◦ 1a—proximal  leak,
◦ 1b—distal  leak,
◦ 1c—exclusion  zone  formed  by  an  iliac  plug  with  aorto-
uni-iliac  devices,
◦ 1d—‘‘gutter’’-like  leak  following  fenestrated  EVAR  or
chimney/periscope  techniques;
type  2:  aneurysm  sac  ﬁlling  via  a  branch  vessel  (for
abdominal  EVAR:  patency  of  the  inferior  mesenteric  or
lumbar  artery);
type  3:  leak  at  the  junction  of  stent-graft  segments.  Three
type-3  subtypes  have  been  described:
◦ 3a—hole  or  defect  within  the  stent-graft,
◦ 3b—leak  between  two  modular  components,
◦ 3c—defective  stent-graft  material;
type  4:  leak  across  the  graft  due  to  its  porosity;
type  5:  ‘‘Endotension’’  leak—no  evidence  of  a  leak  site
can  be  found  but  the  aneurysmal  sac  continues  to  expand.
Depending  on  the  time  to  occurrence,  endoleaks  are
escribed  as  early-onset,  late-onset  or  recurrent.
Endoleaks  that  cause  aneurysmal  sacs  to  be  under  persis-
ent  systemic  pressure  increase  the  risk  of  rupture  [2].
Based  on  the  6787  patients  of  the  Eurostar  registry,  the
ncidence  of  type-1  and  -3  endoleaks  was  6%,  whereas  that
f  type-2  endoleaks  was  5%  [3].  The  frequency  of  type-5
ndoleaks  is  less  well  documented  although  it  was  estimated
t  3.1%  in  the  cohort  of  160  patients  studied  by  Mennander
t  al.  [4].
The  risk  of  rupture  induced  by  post-EVAR  type-1  and  -3
ndoleaks  has  long  been  considered  as  signiﬁcant  [5].
The  risk  of  rupture  related  to  type-2  endoleaks  is  less
lear.  Reinterventions  are  more  frequent  with  this  kind
f  endoleak,  but,  as  shown  by  Van  Marrewijk  et  al.  who
nalyzed  3595  cases  from  the  Eurostar  database,  neither
ost-EVAR  rupture  nor  conversion  to  open  surgery  are  sig-
iﬁcantly  associated  with  type-2  endoleaks  [6].  Among  the
ve  cases  of  type-5  endoleaks  studied  by  Mennander  et  al.,
 were  followed  by  rupture  of  the  aneurysm  [4].
ow can endoleaks be detected?
ngiography
istorically,  angiography  was  used  to  detect  endoleaks
nd  assess  both  antegrade  and  retrograde  ﬂow.  Nowadays
owever,  non-invasive  techniques  are  implemented  with
he  same  results.  In  current  clinical  practice,  angiogra-
hy  is  used  to  assess  the  success  of  endoleak  treatment
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mmediately  after  its  implementation;  it  is  no  longer  used
s  a  detection  technique  or  as  part  of  follow-up.
onventional X-ray imaging
onitoring  the  mechanical  structure  of  the  stent-graft  is
till  an  essential  part  of  follow-up.  Typically,  stent-graft
igration  and  possible  mechanical  defects  (kinking,  dila-
ion,  fracture,  module  or  branch  disconnection,  etc.)  can
e  visualized  clearly  on  anteroposterior  and  oblique  pro-
ections.  However,  endoleaks  cannot  be  visualized  directly
sing  this  imaging  modality.
In  practice,  following  accurate  thresholding,  current
ultislice  CT  techniques  (from  16  slices)  enable  volume
econstruction  and  therefore,  analysis  of  metal  structures.
ence,  conventional  X-ray  imaging  techniques  are  no  longer
sed  to  detect  endoleaks  [7].
omputed tomography
ndoleak  detection  using  CT  is  relatively  simple.  It  is  based
n  detecting,  after  administration  of  contrast  agent,  a  peri-
raft  ﬂow  that  reﬂects  the  ﬂow  of  contrast  out  of  the
tent-graft  and  into  the  aneurysm.  The  radiologist  must
ocate  the  site  of  the  endoleak  precisely,  and  determine
hether  it  involves  the  ends  of  the  stent-graft  (type-1)  and
ther  collateral  vessels  (type-2).  Such  leaks  may  be  detected
ither  in  the  early  arterial  phase  (type-1  and  -3  endoleaks)
r  during  the  delayed  phase  (type-2  endoleaks  and  minor
eaks)  [8]  (Figs.  1—4).
Three  main  disadvantages  are  associated  with  CT  imag-
ng.
etermining the direction of ﬂow
lthough  of  great  importance  for  endoleak  classiﬁcation  and
etermining  the  therapeutic  approach  to  be  used,  the  direc-
ion  of  ﬂow  within  the  aneurysmal  sac  and/or  in  collateral
essels  is  sometimes  difﬁcult  to  detect  with  conventional
T  imaging.  For  example,  opaciﬁcation  of  a lumbar  artery
an  reﬂect  both  a  type-2  endoleak  (retrograde  ﬂow)  and  a
ype-1  endoleak  combined  with  antegrade  ﬂow  into  a  lum-
ar  artery.  As  demonstrated  by  Sommer  et  al.,  this  problem
an  be  overcome  by  using  a  time-resolved  CT  angiographic
rotocol  to  examine  the  patient.  Indeed,  the  authors  recom-
ended  a  protocol  consisting  of  12  low-dose  phases,  with
 scan  frequency  of  5  seconds  and  a scan  range  of  27  cm
9].  This  protocol  resulted  in  the  characterization  of  type-1
ndoleaks  with  an  early  enhancement  time  of  0.28  seconds
±  0.83),  and  type-2  endoleaks  with  a  delayed  enhancement
ime  of  9.17  seconds  (±  3.59).  However,  patient  exposure  to
adiation  with  this  protocol  was  high  with  a  total  dose  of
4.6  mSv.
dministration of iodinated contrast agent
pproximately  80—120  ml  of  iodinated  contrast  agent
s  injected  when  performing  CT  angiography  to  detect
ndoleaks.  In  a  cohort  of  398  patients  monitored  follow-
ng  EVAR,  83%  showed  a  glomerular  ﬁltration  rate  of  less
han  90  ml/min  [10]. In  such  renally-impaired  patients,  clini-
ians  should  either  attempt  to  use  lesser  amounts  of  contrast
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Figure 1. Two lombar arteries (white arrows) responsible of a type-2
responsible of the type-2 endoleak; b: axial slice showing the endoleak a
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of  the  computed  tomography  dose  index  (CTDI).  ForFigure 2. Large type-1 endoleak.
agent  or  completely  eliminate  its  use  by  implementing  an
alternative  method  of  diagnosis.
Exposure to radiation
Long-term  follow-up  protocols  based  on  CT  imaging  mean
that  patients  are  exposed  to  non-negligible  amounts  of  radi-
ation.  When  attempting  to  assess  the  risk  associated  with
radiation  exposure,  White  et  al.  estimated  that  the  summed
radiation  received  during  initial  diagnosis,  stent-graft endoleak (red arrow): a: axial slice showing the lombar arteries
nd aneurysmal sac reinjection.
lacement  and  the  CT  follow-up  protocol  at  1,  3,  6  and
2  months  and  then  yearly  in  patients  aged  70  years,
ncurred  a  risk  of  radiation-induced  cancer  of  0.42%  (1
atient  in  240)  [11].  If  the  patient  was  only  50  years  old
t  the  time  of  stent-graft  placement,  this  risk  was  0.73%
1/140  patient).  Extrapolating  this  risk  of  radiation-induced
ancer  to  elderly  patients  is  probably  excessive,  but  redu-
ing  exposure  to  radiation  should  still  remain  a  priority.
hree  different  manners  of  reducing  exposure  to  radiation
ave  been  proposed:
eliminating  one  of  the  three  phases.  Several  researchers
have  suggested  eliminating  either  the  arterial  phase,
unenhanced  phase  [12]  or  the  delayed  phase  [13],
although  this  has  had  no  real  impact  on  clinical  practice
for  the  moment.  Bley  et  al.  suggested  selecting  patients
needing  to  receive  contrast  based  on  aneurysmal  sac
volume  as  determined  on  non-enhanced  images  [14].
According  to  Stolzmann  et  al.,  a  61%  decrease  in  expo-
sure  to  radiation  could  be  achieved  without  signiﬁcantly
changing  endoleak  detection  performances  by  using  new
dual-energy  dual-source  CT  systems  that  produce  virtual
non-contrast  images  [15];
limiting  the  dose  of  radiation  per  slice.  Various  iter-
ative  reconstruction  algorithms  now  allow  the  use  of
lower  doses  compared  with  the  ﬁltered  back  projec-
tion  algorithms  [16—19].  Reductions  of  up  to  40  and
60%  are  observed  compared  with  ﬁrst-generation  (VISIR:
GE;  IRIS:  Siemens)  and  second-generation  algorithms
(ASiR:  GE;  iDOSE:  Philips;  SAFIRE:  Siemens;  AIDR/AIRDR3:
Toshiba),  respectively.  A  manufacturer  (GE)  offers  now
third-generation  iterative  reconstruction  features.  In  a
recent  prospective  monocentric  study  (Pérignon  et  al.,
submitted  to  Eur.  Radiol.),  we  compared  2nd-generation
ASiR  and  3rd-generation  Veo  iterative  reconstruction  on  a
GE  Discovery  CT750  system  in  a  cohort  of  76  patients.
Patients  underwent  three  phases  with  ASiR,  and  two
phases  with  low-dose  Veo,  based  on  a  50%  reductionendoleak  detection,  the  sensitivity  and  speciﬁcity  of  Veo
were  96%  and  100%,  respectively;  no  endoleaks  were
missed.  The  images  were  of  identical  subjective  quality,
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Figure 3. Type-2 endoleak by lombar reinjection with signiﬁcant aneurysmal diameter expansion: interventionnal procedure is required:
a pe-2
a
•
U
U
o
t
a
i
i
c
d
w
c
a
d
t
ﬁ
s
r
a
1
s
r
g
N
h
p
a
M
T
(
(
F
m
p: axial slice showing the endoleak, lombar artery (red arrow) and ty
rrow).
and  their  objective  quality  was  even  improved  with  Veo
(SNR  =  7.84  with  VEO  vs.  5.14  with  ASiR;  CNR:  5.26  vs.
3.11;  P  <  0.0001).  Use  of  Veo  resulted  in  a  total  reduc-
tion  of  the  effective  dose  of  54%  for  a  series  of  images
compared  to  ASiR  (4.17  mSv  ±  1.43  vs.  9.06  mSv  ±  3.2);
reducing  the  follow-up  schedule  (i.e.  less  CT  examina-
tions).  Until  now  long-term  post-EVAR  follow-up  consisting
of  repeated  CT  examinations  was  considered  to  be  essen-
tial  to  detect  endoleaks  and  rule  out  a  risk  of  rupture.
Possible  modiﬁcations  to  such  protocols  will  be  discussed
below.
ltrasound
ltrasound  examination,  either  contrast-enhanced  or  not,
ffers  the  following  advantages:  it  does  not  induce  renal
oxicity,  avoids  exposure  to  radiation,  and  is  widely  available
nd  relatively  inexpensive  (even  if  CEUS  is  not  reimbursed
n  France).
Ultrasound  is  now  considered  to  be  as  reliable  as  CT  imag-
ng  for  determining  aneurysmal  sac  diameter  [20].
With  contrast-enhanced  ultrasound,  the  direction  of  ﬂow
an  now  also  be  determined  and  hyper-  (low  risk)  and  hypo-
ynamic  endoleaks  can  be  differentiated  based  on  their
ash-in  and  wash-out  times  [21].
Kharthikesalingam  et  al.  performed  a  meta-analysis  to
ompare  various  post-EVAR  follow-up  protocols  [22].  These
d
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igure 4. Follow-up computed tomography before and after contrast
esenteric artery reinjection: a: axial slice before contrast media inje
hase), type-2 endoleak (yellow arrow). endoleak (yellow arrow); b: coronal slice, type-2 endoleak (yellow
uthors  analyzed  25  different  studies  comparing  the  use  of
uplex  Doppler  ultrasound  and  CT  imaging,  for  all  endoleak
ypes,  and  achieved  a  pooled  sensitivity  of  0.74  and  a  speci-
city  of  0.94.  The  pooled  sensitivity  and  speciﬁcity  of  11
tudies  comparing  CEUS  and  CT  scanning  were  0.96  and  0.85,
espectively.  When  only  type-1  and  type-3  endoleaks  were
nalyzed,  the  sensitivity  and  speciﬁcity  reached  0.83  and
 respectively  with  duplex  ultrasound  (pooled  results  of  13
tudies),  and  0.99  and  1,  respectively  with  CEUS  (pooled
esults  of  8  studies).
Ultrasound  is  therefore  beginning  to  replace  CT  as  the
old  standard  imaging  modality  for  post-EVAR  follow-up.
evertheless,  this  technique  also  has  limits  (obese  patients,
ernia,  intestinal  gases,  etc.)  and  cannot  be  used  for  the
ost-TEVAR  follow-up  of  thoracic  aortic  stent-grafts  or  to
ssess  the  mechanical  structure  of  the  stent-graft  (Fig.  5).
agnetic resonance imaging
he  examination  technique  consists  of  a  3D  MR  angiography
MRA)  after  administration  of  a  double  dose  of  gadolinium
4  ml/kg).  Dynamic  contrast-enhanced  time-resolved  MRA
atasets  centered  on  the  endoleak  are  acquired  to  assess
ontrast  kinetics.
MR  imaging  offers  the  advantage  of  no  exposure  to
adiation,  causes  less  or  no  renal  toxicity  and  suggests
 media injection: arterial phase, type-2 endoleak due to inferior
ction; b: same slice level after contrast media injection (arterial
Aortic  stent-grafts:  Endoleak  surveillance  
Figure 5. Abdominal aortic Doppler US follow-up after aneurysm
treatment with endoprosthesis: Doppler US signal in the exclude
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sure)  endoleaks  should  be  treated  immediately  [5].  Type-2aneurysm by a type-2 endoleak due to inferior mesenteric artery
reinjection.
the  direction  of  ﬂow.  Nevertheless,  it  has  3  main
setbacks:
• classic  MRI  contraindications;
• potential  safety  issues,  with  two  associated  risks:
◦ stent-graft  migration,  as  addressed  in  vitro  by  van  der
Laan  et  al.  [23].  Although  nitinol-structure  stent-grafts
are  not  affected  by  this  risk,  other  steel  stent-grafts
(older  Zenith  stents  by  Cook  and  Lifepath  stents  by
Edwards)  could  migrate  in  magnetic  ﬁeld,
◦ the  second  theoretical  risk  is  that  of  stent  heating  [24];
although  to  our  knowledge  no  such  event  has  ever  been
reported  at  1.5  Tesla;
• image  artifacts:
◦ magnetic  susceptibility  artifacts  from  ferromagnetic
stent-grafts  can  distort  the  images  making  them  unin-
terpretable.  Such  artifacts  are  observed  with  nitinol
stent-grafts  but  to  a  much  lesser  degree,
◦ RF  shielding  effects  can  cause  decreased  in-stent
visualization  and  depend  on  stent  geometry  and
conductance  [24,25].
Up  to  present,  MR  imaging  has  not  been  used  on  a  routine
basis  for  stent-graft  follow-up.  A  meta-analysis  including  11
studies  that  compared  MR  with  CT  imaging  (369  patients,
562  MRI  examinations,  562  CT  scans)  demonstrated  that
the  sensitivity  was  greater  with  MRI  than  CT,  especially  for
detecting  type-2  endoleaks  [26].  The  authors  suggested  that
this  modality  be  used  in  the  event  of  aneurysmal  sac  growth
with  negative  or  uncertain  CT  results  (Fig.  6).
Novel alternative follow-up modalities
Manometry
The  risk  associated  with  an  endoleak  being  a  rupture  of  the
aneurysmal  sac  due  to  excessive  pressure,  monitoring  sac
pressure,  represents  an  interesting  approach  for  post-EVAR
follow-up.
e
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The  limits  of  classic  invasive  manometry  are  obvious
introduction  of  an  intrasac  catheter  during  stent-graft
lacement,  or  measurement  by  direct  puncture),  however
lternative  manometric  methods  could  be  feasible.
For  example  in  a  study  by  Ellozy  et  al.,  a  miniaturized
ressure  transducer  was  implanted  within  the  aneurysmal
ac  during  stent-graft  placement,  and  pressure  readings  col-
ected  via  a  receiver  placed  on  the  patient’s  abdomen  [27].
his  device  was  tested  over  a  1-year  period  for  post-EVAR
ollow-up  in  a  series  of  55  patients  and  enabled  the  detec-
ion  of  increased  intrasac  pressure  in  4  out  of  14  patients
ith  type-2  endoleaks  [28].
These  results  still  need  to  be  conﬁrmed  to  demonstrate
he  reliability  of  the  manometer.  A  possible  limitation  of  this
echnique  is  that  it  does  not  provide  any  information  on  how
ressure  is  distributed  within  the  aneurysmal  sac.
onitoring d-dimer levels
lood  d-dimers  are  ﬁbrin  degradation  products  that  are
eleased  during  ﬁbrinolysis.  Increased  d-dimer  levels  are  typ-
cally  observed  after  a recent  thrombotic  event.
Once  exclusion  of  the  aneurysm  sac  has  been  achieved  by
tent-graft  treatment,  a  stable  clot  normally  forms  within
he  sac.  However,  if  blood  continues  to  ﬂow  in  and  out  of
he  sac,  ﬁbrinolysis  can  occur  and  result  in  increased  d-dimer
evels.  In  a  multicenter  study  on  the  post-EVAR  follow-up  of
4  patients,  Serino  et  al.  showed  that,  for  type-1  endoleaks,
-dimer  levels  were  signiﬁcantly  higher  when  the  diame-
er  of  the  aneurysmal  sac  remained  unchanged  or  increased
ompared  with  patients  for  which  the  diameter  of  the  sac
ecreased  [29].  Such  use  of  d-dimer  levels  in  post-EVAR
ollow-up  seems  interesting,  but  to  our  knowledge  these
esults  have  yet  to  be  conﬁrmed.  Also,  it  should  be  noted
hat  this  method  lacks  in  speciﬁcity  since  other  events  can
ause  an  increase  in  d-dimer  levels  during  follow-up.
ost-EVAR surveillance and when to
ntervene
he  2009  guidelines  of  the  French  National  Authority  for
ealth  (Haute  Autorité  de  la  santé  [HAS])  state  that
‘long-term  surveillance  of  patients  after  placement  of  an
bdominal  stent-graft  is  mandatory.  If  such  monitoring  is  not
erformed  then  treatment  should  be  considered  as  incom-
lete.  Monitoring  is  of  the  responsibility  the  surgeon  who
mplanted  the  device  and  should  occur  according  to  a  sched-
le  discussed  with  the  patient’’  [30].
The  main  aim  of  post-EVAR  surveillance  is  to  avoid
neurysmal  sac  rupture  by  measuring  sac  diameter,  and
etecting  and  characterizing  any  potential  endoleaks.
Other  goals  of  post-EVAR  surveillance  are  to  detect
ther  potential  issues  such  as  arterial  access  complications,
enal  artery  occlusion,  risk  of  infection,  stent-graft  migra-
ion,  fracture  or  disconnection  of  modular  components,  and
hrombosis.
It  is  now  acknowledged  that  type-1  and  type-3  (high  pres-ndoleaks  are  treated  if  the  aneurysmal  sac  increases  in  size
31]. Monitoring  is  pursued  if  the  diameter  of  the  aneurys-
al  sac  remains  stable  with  or  without  a  type-2  endoleak
24  L.  Cassagnes  et  al.
Figure 6. Correlation MDCT/MRI of a type-2 endoleak due to lombar reinjection: arterial phase (a) and portal phase (b) MDCT showing
a type-2 endoleak due to lombar artery, with increased reinjection of the aneurysmal sac in the portal phase; c: MRI: arterial and portal
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ndoleak (yellow arrow); d: MRI: axial T2 slice showing a ﬂowing po
but  in  the  absence  of  a  type-1  or  -3  endoleak).  Treatment
ust  be  considered  when  sac  diameter  increases.
Conventional  post-EVAR  follow-up  consists  of  immediate
ostoperative  CT  imaging,  then  repeated  CT  scans  at  1,  3,
 and  12  months,  and  then  yearly.
MR  imaging  is  used  for  stent-grafts  made  from  non-  or
eakly  ferromagnetic  materials  when  CT  is  contraindicated.
se  of  duplex  Doppler  ultrasound  examination  is  still  not
stablished.
As  discussed  above,  recent  advances  in  the  use  of  ultra-
ound  and  MR  imaging,  together  with  the  risks  related  to
xposure  to  X-ray  radiation  and  contrast  agent  and  the  cost
f  CT  imaging,  tend  to  suggest  that  post-EVAR  follow-up
rotocols  will  change  in  the  not  too  distant  future.
VS Practice Guidelines 2009
he  Society  of  Vascular  Surgery  (SVS)  recommends  the  fol-
owing  post-EVAR  follow-up  protocol  [32]:
CT  scan  at  one  month  and  12  months.  Then,  if  no  endoleak
or  no  increase  in  aneurysmal  sac  size  is  observed,  color
Doppler  ultrasound  can  be  used  for  yearly  surveillance  as
an  alternative  to  CT  scanning.  CT  examination  must  be
carried  out  at  6  months  if  any  abnormalities  are  detected
at  the  1-month  visit;
i
f
ld individualization of the lombar artery responsible of the type-2
 at the posterior portion of the aneurysm normally exclude.
type-2  endoleaks  are  monitored  using  CT,  then  if  the  diam-
eter  of  the  aneurysmal  sac  remains  constant  or  decreases,
using  Doppler  ultrasound;
any  new  endoleaks  detected  must  be  characterized,  and
type-1  and  -3  endoleaks  treated  by  exclusion;
in  renally-impaired  patients,  combined  follow-up  using
Doppler  ultrasound  and  non-contrast  enhanced  CT  can  be
used  as  a  suitable  alternative  to  contrast-enhanced  CT.
Among  the  issues  that  remain  outstanding  with  these
uidelines  is  the  frequency  of  follow-up  visits  which  will
robably  need  adjusting  in  the  future  to  deﬁne  three  dif-
erent  post-EVAR  follow-up  periods:  0—5  years,  5—10  years
nd  10—15  years.  One  should  also  bear  in  mind  the  beneﬁt
rovided  by  surveillance  of  the  rest  of  the  arterial  network
n  these  patients  with  atheromatous  disease.
Fig.  7  shows  the  protocol  proposed  by  H.  Rousseau  in  2013
or  the  French  Society  for  Cardiovascular  Imaging  (Société
ranc¸aise  d’imagerie  cardiovasculaire  [SFICV])  and  modiﬁed
rom  the  North-American  consensus  described  by  Sternbergh
t  al.  [33].The  main  limitation  of  this  protocol  is  that  the  mechan-
cal  structure  of  the  stent-graft  cannot  be  assessed  when
ollow-up  is  based  on  ultrasound  examination.  The  surveil-
ance  of  stent-graft  structure  and  its  potential  migration
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1Figure 7. Follow-up protocol proposed by H. Rousseau in 2013 fo
being  essential,  this  protocol  would  therefore  beneﬁt  from
complementary  conventional  X-ray  imaging.
Prospects
Without  doubt,  the  current  consensus  on  post-EVAR  follow-
up  will  undergo  changes  in  the  not  too  distant  future.
It  is  now  recognized  that  lethal  post-EVAR  complications
are  observed  more  frequently  in  inadequately-monitored
patients  than  in  patients  who  attend  regular  follow-up
visits  [34].  Long-term  surveillance  is  also  important  as  new
endoleaks  have  been  detected  up  to  7  years  after  EVAR  [35].
Moreover,  if  the  meta-analysis  conducted  in  2010  by  Nor-
don  et  al.  based  on  32  studies  including  17,987  EVAR  patients
demonstrated  that  90%  of  patients  did  not  beneﬁt  from
follow-up,  the  remaining  10%  of  patients  deﬁnitely  did  [36].
Sternbergh  et  al.  also  discussed  the  possibility  of  identifying
at  an  early  stage  sub-populations  of  patients  at  a  high  risk  of
complications  and  speciﬁcally  adjusting  the  follow-up  pro-
tocol  to  take  such  risks  into  account  [33].  This  would  mean
deﬁning  various  prediction  criteria.  Some  of  these  predic-
tion  criteria  are  already  established:
• preoperative  criteria:  aneurysmal  sac  diameter;  short  and
angulated  neck  [37];
• postoperative  criteria:
◦ reduction  of  aneurysmal  sac  diameter:  decreased  sac
size  at  12  months  is  indicative  of  long-term  success  [38],
◦ no  endoleaks  at  1  month:  The  Zenith  multicenter  trial
conducted  in  the  USA  demonstrated  that  in  such
patients  the  aneurysm-related  morbidity  and  mortality
was  lower  than  in  patients  with  an  endoleak  at  1  month
and  that  CT  imaging  at  6  months  provided  no  additional
t
t
t
v SFICV, modiﬁed from the North-American consensus [29].
beneﬁt  if  CT  results  were  normal  at  one  month  [33].
The  Powerlink  trial  (Endologix)  including  345  patients
and  1591  CT  scans  showed  that  the  negative  predictive
value  of  secondary  post-EVAR  CT  imaging  was  96.4%,
whereas  it  was  97.6%  for  ultrasound  [39],
◦ ﬁnally,  the  absence  of  early-onset  endoleaks  and  the
presence  of  an  adequate  proximal  and  distal  stent  seal
(>  10  mm)  can  be  used  to  characterize  a  sub-population
of  low-risk  patients,  for  whom  follow-up  is  recom-
mended  at  5  years  [40].
onclusion
ype-1  and  type-3  (high  pressure)  endoleaks  should  be
reated  immediately  whereas  type-2  endoleaks  should  only
e  treated  if  aneurysmal  sac  size  increases.  Monitoring  is
ursued  if  the  diameter  of  the  aneurysmal  sac  remains  sta-
le  with  or  without  a  type-2  endoleak  (but  in  the  absence
f  a  type-1  or  -3  endoleak).  If  aneurysmal  sac  diameter
ncreases,  clinicians  should  strive  to  detect  and  characterize
he  endoleak,  using  another  imaging  modality  if  necessary,
nd  treat  it  either  using  interventional  radiology  techniques
r  by  conversion  to  open  surgery.
CT  imaging  is  the  gold  standard  and  enables  clinicians
o  simultaneously  detect  endoleaks  and  assess  the  mechan-
cal  structure  of  the  stent-graft.  It  should  be  performed  at
 and  12  months  post-EVAR.  Nonetheless,  CT  imaging  has
hree  main  disadvantages:  poor  ﬂow  detection,  administra-
ion  of  contrast  agent,  and  exposure  to  radiation.  Exposure
o  radiation  could  be  reduced  in  several  manners,  notably
ia  the  use  of  new  dual-energy  CT  systems  (that  eliminate
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he  need  to  perform  non-contrast  enhanced  imaging),  iter-
tive  reconstruction  and  adapting  (reducing)  the  follow-up
chedule  based  on  individual  patient  requirements.
Optimized  contrast-enhanced  ultrasound  is  becoming  for
any  clinicians  the  new  gold  standard  for  surveillance  of
ost-EVAR  patients  without  endoleaks  from  one  year  on.  The
eed  to  ascertain  stent-graft  structure  and  non-migration  in
he  long-term  raises  the  possibility  of  adding  conventional
-ray  imaging  to  this  protocol  as  a  complement  to  CEUS
xamination.
MR  imaging  (for  stent-grafts  made  of  non-ferromagnetic
aterial)  is  required  if  the  size  of  the  aneurysmal  sac  con-
inues  to  increase  and  CT  results  are  negative  or  uncertain.
A  shift  in  practice  is  underway  towards  patient-adjusted
rotocols  based  on  each  individual  patient’s  risk  of
omplications  that  take  into  account  preoperative  imag-
ng  (sac  diameter,  short  and  angulated  neck)  and  the  initial
ostoperative  results  (reduction  in  sac  diameter,  absence  of
ndoleaks  on  CT  imaging  at  1  month,  and  adequate  proximal
nd  distal  sealing).
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